Pacritinib Versus Best Available Therapy to Treat Patients With Myelofibrosis and Thrombocytopenia
Public ClinicalTrials.gov record NCT02055781. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Controlled Phase 3 Study of Oral Pacritinib Versus Best Available Therapy in Patients With Thrombocytopenia and Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Phase 3, randomized, controlled study to evaluate the safety and efficacy of oral pacritinib compared to Best Available Therapy (BAT) in patients with thrombocytopenia and primary or secondary myelofibrosis.
Study identification
- NCT ID
- NCT02055781
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 311 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2014 (Actual)
- Primary completion
- Apr 2016 (Actual)
- Completion
- Apr 2016 (Actual)
- Last update posted
- Nov 18, 2021
2014 – 2016
United States locations
- U.S. sites
- 50
- U.S. states
- 25
- U.S. cities
- 45
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic Arizona | Scottsdale | Arizona | 85259 | — |
| Arizona Clinical Research Center | Tucson | Arizona | 85715 | — |
| City of Hope | Duarte | California | 91010 | — |
| Moores Cancer Centre | La Jolla | California | 92093 | — |
| USC Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | — |
| Stanford Cancer Center | Stanford | California | 94305 | — |
| Rocky Mountain Cancer Center | Boulder | Colorado | 80303 | — |
| George Washington University- Medical Faculty Associates | Washington D.C. | District of Columbia | 20037 | — |
| SCRI- Florida Cancer Specialists South Region | Fort Myers | Florida | 33916 | — |
| SCRI - Florida Cancer Specialists North Region | St. Petersburg | Florida | 33705 | — |
| H. Lee Moffitt Cancer Center & Research Institute | Tampa | Florida | 33612 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| Carle Cancer Center | Urbana | Illinois | 61801 | — |
| Indiana University Goshen Cancer Centre | Goshen | Indiana | 46526 | — |
| Investigative Clinical Research of Indiana | Indianapolis | Indiana | 46260 | — |
| University of Iowa Hospitals and Clinics | Iowa City | Iowa | 52242 | — |
| Siouxland Hematology-Oncology Associates, L.L.P (SHOA) | Sioux City | Iowa | 51101 | — |
| Norton Cancer Institute, Suburban | Louisville | Kentucky | 40207 | — |
| St Joseph Mercy Hospital | Ann Arbor | Michigan | 48106 | — |
| University of Michigan | Ann Arbor | Michigan | 48109 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| Providence Cancer Institute | Southfield | Michigan | 48075 | — |
| Washington University School of Medicine Division of Oncology | St Louis | Missouri | 63110 | — |
| Nebraska Hematology-Oncology, P.C. | Lincoln | Nebraska | 68506 | — |
| Hackensack University | Hackensack | New Jersey | 07601 | — |
| Hematology-Oncology Associates of Northern Jersey | Morristown | New Jersey | 07962 | — |
| New Mexico Cancer Care Alliance | Albuquerque | New Mexico | 87106 | — |
| Mount Sinai Medical Center | New York | New York | 10029 | — |
| Columbia University Medical Center | New York | New York | 10032 | — |
| Stony Brook University Medical Center | Stony Brook | New York | 11794 | — |
| SCRI-Oncology Hematology Care | Cincinnati | Ohio | 45242 | — |
| Cleveland Clinic-Taussig Cancer Center | Cleveland | Ohio | 44195 | — |
| University of Oklahoma | Oklahoma City | Oklahoma | 73104 | — |
| Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | — |
| UPMC Hillman Cancer Center | Pittsburgh | Pennsylvania | 15232 | — |
| Upstate Oncology Associates | Greenville | South Carolina | 29601 | — |
| Sarah Cannon Research Institute (SCRI) | Nashville | Tennessee | 37203 | — |
| Texas Onocolgy-Baylor Sammons Cancer Center | Dallas | Texas | 75246 | — |
| UT Southwestern Medical Center | Dallas | Texas | 75390 | — |
| UTMB Galveston | Galveston | Texas | 77555 | — |
| Houston Methodist | Houston | Texas | 77030 | — |
| University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| Cancer Care Centers of South Texas | San Antonio | Texas | 78229 | — |
| Huntsman Cancer Hospital | Salt Lake City | Utah | 84112 | — |
| Virginia Cancer Specialists | Leesburg | Virginia | 20176 | — |
| Providence Regional Cancer Partnership | Everett | Washington | 98201 | — |
| Fred Hutchinson Cancer Research Center | Seattle | Washington | 98109 | — |
| Green Bay Oncology | Green Bay | Wisconsin | 54301 | — |
| Froedtert Hospital and the Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 72 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02055781, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 18, 2021 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02055781 live on ClinicalTrials.gov.